Company Name, Ticker, Industry, else..

Moderna Inc (NASDAQ: MRNA)

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Moderna Inc 's

Name: Moderna Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRNA Sales vs. its Competitors Q2 2026

Comparing the current results to its competitors, Moderna Inc reported Revenue increase in the 2 quarter 2026 by 2.11 % year on year.
The revenue growth was below Moderna Inc 's competitors' average revenue growth of 5.63 %, achieved in the same quarter.

• List of MRNA Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Moderna Inc , slower than the average decrease reported by the company's competitors of -72.32 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -72.32 %

<< MRNA Stock Performance Comparisons

Moderna Inc 's Comment on Competition and Industry Peers

The company operates in the biotechnology and pharmaceutical industry, focusing on mRNA medicines. It faces competition from large pharmaceutical companies, biotechnology firms, academic institutions, government agencies, and research institutions. The growth of the mRNA field has intensified competition, particularly from established pharmaceutical companies. In the seasonal vaccines market, the company primarily competes with Pfizer and BioNTech for sales of COVID-19 vaccines based on mRNA technology.

<< See the full list of MRNA competitors

Overall company Market Share Q2 2026

Overall company revenue, grew with moderate pace of 2.11 % slower than competitors within this segment. << More on MRNA Market Share.

*Market share is calculated based on total revenue.

MRNA's Stock Performance relative to its Competitors

Publicly Traded Peers of Moderna Inc

Sana Biotechnology Inc
Share Performance

-13.35%

30 Days

Sana Biotechnology Inc

Profile

Sana Biotechnology Inc operates as a biotechnology company that focuses on developing and commercializing cellular therapies for various diseases. Their business model involves leveraging innovative technologies and collaborations with clinical and industry partners to develop advanced medical treatments.

More about Sana Biotechnology Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 940.221 mill.	$ - mill.	$ -211.822 mill.

Immunitybio inc
Share Performance

+8.30%

30 Days

Immunitybio inc

Profile

Immunitybio Inc operates on a business model that focuses on developing and commercializing innovative immunotherapies and vaccines to address various diseases and medical conditions. They aim to use their broad scientific expertise, technology platforms, and strategic partnerships to advance their products and improve patient outcomes in healthcare.

More about Immunitybio inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 8,699.830 mill.	$ 165.792 mill.	$ -992.419 mill.

Hillevax Inc
Share Performance

+6.09%

This Quarter

Hillevax Inc

Profile

Hillevax Inc's business model is centered around a specific product or service that they offer to customers.

More about Hillevax Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 104.739 mill.	$ - mill.	$ -71.097 mill.

Evaxion A
Share Performance

+5.14%

One Year

Evaxion A

Profile

Evaxion Biotech is a company that operates on a business model centered around the development and commercialization of innovative immunotherapies, leveraging artificial intelligence and machine learning technologies to identify and target specific antigens for the treatment of cancer and infectious diseases. These therapies are intended to improve patient outcomes and bring about advancements in the field of precision medicine.

More about Evaxion A's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ 7.565 mill.	$ -12.538 mill.

Tradeup Acquisition Corp
Share Performance

-40.05%

This Quarter

Tradeup Acquisition Corp

Profile

Estrella Immunopharma Inc is a biotechnology company that focuses on developing innovative immunotherapies. They have a business model centered around researching, developing, and commercializing novel treatments for various diseases. Their approach includes leveraging the power of the immune system to target and eradicate diseases, with a particular emphasis on cancer.

More about Tradeup Acquisition Corp's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 27.325 mill.	$ - mill.	$ -17.378 mill.

129 more competitors available

Sources: Moderna Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, September 14, 2026 4:04 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Moderna Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.